MedTech Accelerator: Rapid Regulatory Support Fund (MARRS)

New £5 million accelerator programme to support UK MedTech innovation

The Centre for Process Innovation Limited (CPI) and the Office for Life Sciences (OLS) have joined forces to deliver the MedTech Accelerator: Rapid Regulatory Support Fund (MARRS), a £5 million programme funded by UK Government aimed at supporting and enabling growth in the vital UK MedTech industry.

The programme will provide up to 140 MedTech SMEs with a grant of up to £30,000 to tackle key regulatory challenges.

MedTech innovations can help to solve major healthcare challenges, provide vast patient benefits, and reduce long NHS waiting lists, however the industry faces significant challenges.

What is the MARRS Fund?

The new MARRS fund is designed to help start-ups and SMEs access essential regulatory advice. Companies can apply for a grant of up to £30,000 to fund external regulatory guidance and support, helping them accelerate the development of new, safe and effective devices to market or keep critical devices available to patients in compliance with new regulatory requirements. SMEs are encouraged to submit applications as soon as possible.

The programme will support SMEs that rely on external expertise to commercialise new products or re-register existing products in line with new regulatory requirements. SMEs working in MedTech can apply for funding for use with regulatory affairs providers to help with navigating regulatory pathways.

There is a total of £4.2m Innovate UK investment, with projects to be awarded up to £30,000 per UK SME. SMEs can apply for reimbursement of activities conducted with an independent regulatory affairs consultant.

Eligibility criteria

Only UK-based SMEs are eligible to apply to this programme.

• Applications will only be accepted from and will be awarded to a single legal entity.  Only one application per company or company group is allowed.   
• Applications must be from a UK registered SME company which is developing or currently producing and selling MedTech as they are outlined in the Medicines & Medical Devices Act 2021

How to apply

Apply to the Rapid Regulatory Support Fund Programme.

First published 11 October 2024